Effects of wholegrain components on metabolic biomarkers: a four-week intervention study in 'at risk' subjects

ISRCTN ISRCTN93336504
DOI https://doi.org/10.1186/ISRCTN93336504
Protocol serial number N/A
Sponsor European Commission (Belgium)
Funder HEALTHGRAIN (Europe) - an integrated 6th framework European Union (EU) project (ref: FOOD-CT-2005-514008)
Submission date
03/09/2008
Registration date
04/12/2008
Last edited
05/07/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Other
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Robert Welch
Scientific

Northern Ireland Centre for Food and Health (NICHE)
Biomedical Sciences
University of Ulster
Cromore Road
Coleraine
BT52 1SA
United Kingdom

Phone +44 (0)28 7032 4205
Email rw.welch@ulster.ac.uk

Study information

Primary study designInterventional
Study designSingle centre randomised single blind parallel controlled study
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific title
Study objectivesLong-term consumption of bran-rich cereal products impacts favourably on risk factors for heart disease and metabolic syndrome in apparently healthy, 'at risk' men and women.
Ethics approval(s)The study was approved by the University of Ulster Research Ethics Committee in March 2007 (ref: REC/07/0016).
Health condition(s) or problem(s) studiedChronic diseases, particularly cardiovascular disease and cancers
InterventionVolunteers were stratified by age and sex and randomly assigned into the test or control group:
1. Test group: 3 x high-bran products per day for 4 weeks (1 x ready-to-eat cereal + 2 x bread products)
2. Control group: 3 x refined high-fibre products per day for 4 weeks (1 x ready-to-eat cereal + 2 x bread products)

Test and control products were balanced for energy, fibre and macronutrients and incorporated by volunteers into their normal diet.
Intervention typeDrug
PhaseNot Specified
Drug / device / biological / vaccine name(s)Bran-rich cereal products
Primary outcome measure(s)

Changes in plasma homocysteine (a risk marker for CHD) attributable to treatment during the intervention, measured at baseline and 4 weeks.

Key secondary outcome measure(s)

Changes in other risk markers for disease attributable to treatments during the intervention:
1. Inflammatory markers and endothelial function
2. Antioxidant status
3. Lipid profile
4. Relevant micronutrient levels
5. Insulin and glucose levels

Outcomes measured at baseline and 4 weeks.

Completion date04/06/2008

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration80
Key inclusion criteria1. Healthy men and women aged between 45 - 65 years
2. Body Mass Index (BMI) greater than 25 kg/m^2

This inclusion criteria were selected as such individuals are thought to be at a slightly greater risk of chronic disease.
Key exclusion criteria1. Smokers
2. People on special diets (e.g. vegetarians, coeliac patients)
3. People with diabetes
4. Pre-existing chronic disease
5. Regular use of prescription medicine, including statins and blood pressure medication
6. People who regularly take any vitamin or mineral supplement or have done so in the last 6 months
7. Women who are pregnant or lactating
8. People who have given blood to the blood transfusion service (BTS) within the past 4 months
Date of first enrolment15/12/2007
Date of final enrolment04/06/2008

Locations

Countries of recruitment

  • United Kingdom
  • Northern Ireland

Study participating centre

Northern Ireland Centre for Food and Health (NICHE)
Coleraine
BT52 1SA
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 14/11/2012 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
Study website Study website 11/11/2025 11/11/2025 No Yes